Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Geenen, Joost W"'
Autor:
Geenen, Joost W., Belitser, Svetlana V., Vreman, Rick A., van Bloois, Martijn, Klungel, Olaf H., Boersma, Cornelis, Hövels, Anke M.
Publikováno v:
The European Journal of Health Economics, 2020 Aug 01. 21(6), 845-853.
Externí odkaz:
https://www.jstor.org/stable/45287116
Publikováno v:
The European Journal of Health Economics, 2019 Aug 01. 20(6), 857-867.
Externí odkaz:
https://www.jstor.org/stable/45157025
Autor:
Geenen, Joost W.1 (AUTHOR), Jut, Mark1 (AUTHOR), Boersma, Cornelis2,3 (AUTHOR), Klungel, Olaf H.1 (AUTHOR) o.h.klungel@uu.nl, Hövels, Anke M.1 (AUTHOR)
Publikováno v:
Journal of Market Access & Health Policy. Dec2020, Vol. 8 Issue 1, p1-8. 8p.
Autor:
Vreman, Rick A, Geenen, Joost W, Hövels, Anke M, Goettsch, Wim G, Leufkens, Hubert G M, Al, Maiwenn J, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Applied Health Economics and Health Policy, 17(6). Springer International Publishing AG
Applied Health Economics and Health Policy
Applied Health Economics and Health Policy, 17, 883-893. Springer International Publishing AG
Applied Health Economics and Health Policy
Applied Health Economics and Health Policy, 17, 883-893. Springer International Publishing AG
Objectives The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot
Autor:
Geenen, Joost W., Vreman, Rick A., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Cost Effectiveness and Resource Allocation, 18(1). BioMed Central
Cost Effectiveness and Resource Allocation, 18(1):54, 1-10. BMC
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-10 (2020)
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation, 18(1):54, 1-10. BMC
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-10 (2020)
Cost Effectiveness and Resource Allocation : C/E
Background Results of probabilistic sensitivity analyses (PSA) are frequently visualized as a scatterplot, which is limited through overdrawing and a lack of insight in relative density. To overcome these limitations, we have developed the Relative D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca89142a003003a88046419a7074e14
https://dspace.library.uu.nl/handle/1874/410824
https://dspace.library.uu.nl/handle/1874/410824
Autor:
Geenen, Joost W., Vreman, Rick A., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M., Ham, Renske M. T. Ten
Additional file 2: Technical appendix.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e8138fa7a345854804123ae17267923
Autor:
Vreman, Rick A., Geenen, Joost W., Knies, Saskia, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G.M., Goettsch, Wim G., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Pharmacoeconomics
Pharmacoeconomics (Print). Adis
PharmacoEconomics, 39(1), 1. Adis International Ltd
Pharmacoeconomics (Print). Adis
PharmacoEconomics, 39(1), 1. Adis International Ltd
Deterministic sensitivity analyses (DSA) remain important to interpret the effect of uncertainties in individual parameters on results of cost-effectiveness analyses. Classic DSA methodologies may lead to wrong conclusions due to a lack of or mislead
Autor:
Geenen, Joost W., Vreman, Rick A., Boersma, Cornelis, Klungel, Olaf H., Hövels, Anke M., Ham, Renske M. T. Ten
Additional file 1: Additional figures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a39bdc2ed025484c38d795c07150fd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.